Medacta Launches Short Humeral Diaphysis for the Medacta Shoulder System at the San Diego Shoulder Institute’s Annual Shoulder Course

Medacta® International, the privately held family-owned
global leader in the design of innovative joint replacement and spine
surgery products, today announced clearance by the U.S. Food and Drug
Administration (FDA) for its Short Humeral Diaphysis, which is utilized
with the Medacta
Shoulder System. The company will showcase this new product at the San
Diego Shoulder Institute’s (SDSI) Annual Shoulder Course, held June
20-23 in San Diego at Booth #310. Medacta will host numerous “Meet the
Expert” opportunities with orthopedic surgeon designers Matthew
Saltzman, M.D., and Anup Shah, M.D., throughout the conference and lead
cadaveric workshops on Thursday, June 21 as a part of its M.O.R.E.

The Short Humeral Diaphysis is an implantable device that replaces the
humeral side of the gleno-humeral joint and is intended for use with the
Medacta Shoulder System as an alternative to the Standard Humeral
Diaphysis. The Short Humeral Diaphysis is indicated for primary and
reverse shoulder replacement in patients suffering from severe
arthropathy or a grossly deficient rotator cuff. Through a reduction in
device length, the corresponding procedure minimizes the violation of
the humeral intramedullary canal (IM). The device is manufactured from
titanium alloy and will be offered in 11 sizes to provide a
patient-matched fit.

“Medacta is constantly looking to expand its product offerings to
accommodate the largest group of unique patient anatomies as possible,”
said Francesco Siccardi, Executive Vice President of Medacta
International. “We’ve experienced a very positive response to our recent
expansion into the shoulder market and are looking to build on that
success. The addition of the Short Humeral Diaphysis to the Medacta
Shoulder System means that surgeons will be able to achieve a more
personalized fit for more patients, improving the patient and surgeon

Medacta Activities at SDSI’s 35th Annual
Shoulder Course

Medacta will showcase this new product at Booth #310 along with the full
Medacta Shoulder System and will offer various opportunities for
conference attendees to experience its products and meet with members of
the team. The full schedule of Medacta’s on-site offerings is listed

Thursday, June 21: Medacta Shoulder System Cadaveric Workshops

Wednesday, June 20-Friday, June 22: “Meet the Experts” Sessions with
Drs. Saltzman and Shah

Conference attendees interested in scheduling “Meet the Expert”
appointments or attending Medacta’s wet lab sessions should contact
Amanda Earl (aearl@medacta.us.com).
Additional workshops may be added to the schedule to accommodate
requests, as needed.

About the M.O.R.E. Institute – “Where the surgeon is never alone”

Strongly aware of its role to provide continuing education as products
and techniques evolve, Medacta International founded the M.O.R.E.
(Medacta Orthopaedic Research and Education) Institute to highlight this
commitment. Built on the ideal of sharing experience within the
international medical community, the mission of the M.O.R.E. Institute
is to provide ongoing support to Medacta partners worldwide as they
strive to make an impact by learning about and adopting emerging
technologies, surgical techniques and orthopaedic products. The
Institute includes the AMIS Education Program for total hip
arthroplasty, which has revolutionized the teaching of the anterior
approach to hip replacement throughout the world, as well as platforms
to impact the specialties of partial and total knee arthroplasty, total
and reverse shoulder arthroplasty, sports medicine and spine surgery.
The Institute relies on Medacta consultants and the healthcare provider
community to create networking opportunities and hundreds of educational
events, including courses, wet labs, scientific evenings,
surgeon-to-surgeon visits, international symposia, guesting and hosting
thousands of participants from all over the world. With a strong focus
on young and promising surgeons, the M.O.R.E. Institute also supports
fellowship programs worldwide.

About Medacta International

Medacta® International is a world leading manufacturer of
orthopedic implants, neurosurgical systems and instrumentation.
Medacta’s revolutionary approach and responsible innovation have
resulted in standard of care breakthroughs in hip replacement with the
AMIS® system and total knee replacement with MyKnee®
patient-matched technology. Over the last 10 years, Medacta has grown
dramatically by taking a different approach and placing value on all
aspects of the care experience from design to training to
sustainability. Medacta is headquartered in Castel San Pietro,
Switzerland, and operates in over 30 countries. To learn more about
Medacta International, please visit www.medacta.com
or follow @Medacta
on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180618005072/en/